Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > TOP STORIES
TOP STORIES
-
BUSINESS Eisai, Ajinomoto Link Arms to Create Leading Specialty Pharma for GI Disease
October 16, 2015
-
REGULATORY Chuikyo Tilting Toward Introduction of Re-Pricing for “Huge Seller” Drugs
October 15, 2015
-
ORGANIZATION AMDJ to Draw Up Voluntary Rules for Managing Big Data in Field of Healthcare
October 14, 2015
-
REGULATORY MOF Pitches Reimbursement Rate Cuts for OTC-Switched Ethical Drugs, Submission of Related Bills Eyed in 2017
October 13, 2015
-
REGULATORY TPP Will Have No Impact on Japan’s Universal Care Scheme: Negotiator
October 9, 2015
-
REGULATORY Chuikyo Payer and Doctor Reps Exchange Barbs on Spike in Generic Brand-Specified Scripts
October 8, 2015
-
REGULATORY 8 Year Biologic Data Protection in TPP Won’t Affect Japan: MHLW Official
October 7, 2015
-
REGULATORY MHLW Looks to Establish Panel to Draft Guidelines for English-Language Inserts
October 6, 2015
-
BUSINESS Belsomra Most Heavily Pitched Drug in July: Anterio Ranking
October 5, 2015
-
ORGANIZATION Drug Pricing Tomorrow: Full Interview with JMA Vice President Nakagawa
October 5, 2015
-
ORGANIZATION New 3 Price-Band Rule Will Boost Predictability, Foster Healthy Competition: JGA Officials
October 2, 2015
-
REGULATORY Chuikyo Debate Heats Up on Number of Generic Brands, Makers; JGA Floats New 3 Price-Band Rule
October 1, 2015
-
ORGANIZATION “Humanitarian Trials” Not Welcomed but Well-Designed: JPMA Regulatory Chief
September 30, 2015
-
ORGANIZATION Drug Pricing Tomorrow: JMA’s Nakagawa Says Price Maintenance Premium Should Continue as Trial Measure
September 29, 2015
-
REGULATORY Health Policy Bureau Chief Futagawa Tapped for MHLW’s Top Bureaucratic Post
September 28, 2015
-
BUSINESS Terumo Aims at Annual Sales of 1-2 Billion Yen for HeartSheet within 5-10 Years
September 25, 2015
-
REGULATORY Drug Pricing Tomorrow: Full Interview with MOF Budget Examiner Unami
September 25, 2015
-
REGULATORY One-Month Lag in Regulatory Filing Accepted for Sakigake Designation
September 24, 2015
-
ORGANIZATION JPMA Reprimands Pfizer over Failure to Report ADRs
September 18, 2015
-
ORGANIZATION JPMA Helping Member Firms Expand into Emerging Asian Markets: Int’l Affairs Chief
September 17, 2015
ページ
Japan is opening a new chapter in sleep medicine. The recent decision to allow medical institutions to advertise “sleep disorders”…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…